CLBTW (Cellebrite DI) Cash Flow from Financing: $24.94 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CLBTW Cellebrite DI Ltd CLBTW
85 GF Score
Price $5.25
! 3 Warning Signs
View Full Analysis

What is Cellebrite DI Cash Flow from Financing?

Cellebrite DI CLBTW 85 Cash Flow from Financing is $24.94 Mil as of Mar. 2026. GuruFocus rates CLBTW with a GF Score™ of 85/100. The stock has 3 warning signs investors should review.

Cash from financing is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders.

For the three months ended in Mar. 2026, Cellebrite DI paid $0.00 Mil more to buy back shares than it received from issuing new shares. It received $0.00 Mil from issuing more debt. It paid $0.00 Mil more to buy back preferred shares than it received from issuing preferred shares. It received $0.00 Mil from paying cash dividends to shareholders. It received $0.00 Mil on other financial activities. In all, Cellebrite DI spent $0.00 Mil on financial activities for the three months ended in Mar. 2026.


Cellebrite DI  (NAS:CLBTW) Cash Flow from Financing Explanation

Cash from financing contains six items:

1. Issuance of Stock:
A company may raise cash from issuing new shares. Issuance of stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.

Cellebrite DI's issuance of stock for the three months ended in Mar. 2026 was $0.00 Mil.

2. Repurchase of Stock:
A company may raise cash from issuing new shares. It can also use cash to buy back shares. Repurchase of stock represents the cash outflow to reacquire common stock during the period.

Cellebrite DI's repurchase of stock for the three months ended in Mar. 2026 was $0.00 Mil.

3. Net Issuance of Debt:
Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.

Cellebrite DI's net issuance of debt for the three months ended in Mar. 2026 was $0.00 Mil. Cellebrite DI received $0.00 Mil from issuing more debt.

4. Net Issuance of Preferred Stock:
A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Cellebrite DI's net issuance of preferred for the three months ended in Mar. 2026 was $0.00 Mil. Cellebrite DI paid $0.00 Mil more to buy back preferred shares than it received from issuing preferred shares.

5. Cash Flow for Dividends:
Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Cellebrite DI's cash flow for dividends for the three months ended in Mar. 2026 was $0.00 Mil. Cellebrite DI received $0.00 Mil from paying cash dividends to shareholders.

6. Other Financing:
Money spent or earned by company from other financial activities.

Cellebrite DI's other financing for the three months ended in Mar. 2026 was $0.00 Mil. Cellebrite DI received $0.00 Mil on other financial activities.


Cellebrite DI Cash Flow from Financing Related Terms


Cellebrite DI Cash Flow from Financing Historical Data

* Premium members only.

The historical data trend for Cellebrite DI's Cash Flow from Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cellebrite DI Cash Flow from Financing Chart

Cellebrite DI Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cash Flow from Financing
Get a 7-Day Free Trial -68.40 13.97 21.77 20.65 25.05

Cellebrite DI Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cash Flow from Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.62 13.83 5.27 2.34 3.51
CLBTW
85GF Score
Cellebrite DI Ltd CLBTW
Cash Flow from Financing is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cellebrite DI Cash Flow from Financing Calculation

This is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders. In the calculation of free cash flow, cash from financing is not calculated because it is not related to operating activities.

Cellebrite DI's Cash from Financing for the fiscal year that ended in Dec. 2025 is calculated as:

Cellebrite DI's Cash from Financing for the quarter that ended in Mar. 2026 is:


Cash Flow from Financing for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $24.94 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Cash Flow from Financing of $24.94 Mil mean?
Cellebrite DI (CLBTW) has a Cash Flow from Financing of $24.94 Mil as of Mar. 2026. Cash Flow from Financing is the amount of cash earned or paid from financing operations. View historical data for Cellebrite DI and its competitors.
Is Cellebrite DI's Cash Flow from Financing too high?
Cellebrite DI's current Cash Flow from Financing is $24.94 Mil. Overall, Cellebrite DI has a GF Score™ of 85/100, reflecting its overall financial health beyond just this single metric.
How does Cellebrite DI's Cash Flow from Financing compare to TENB and PAY?
Cellebrite DI's Cash Flow from Financing of $24.94 Mil can be compared against companies in the Software industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Flow from Financing for a Software company?
A good Cash Flow from Financing depends on the Software industry context. However, Cash Flow from Financing should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Flow from Financing mean?
A high Cash Flow from Financing can signal that a stock is expensive relative to its fundamentals. Cash Flow from Financing is the amount of cash earned or paid from financing operations. View historical data for Cellebrite DI and its competitors. Cellebrite DI's current Cash Flow from Financing is $24.94 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cellebrite DI stock overvalued right now?
Cellebrite DI (CLBTW) has a current Cash Flow from Financing of $24.94 Mil. The current Cash Flow from Financing is $24.94 Mil. Cellebrite DI's overall GF Score™ is 85/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Flow from Financing calculated?
Cash Flow from Financing is calculated from a company's financial statements. For Cellebrite DI (CLBTW), the current Cash Flow from Financing is $24.94 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cellebrite DI Business Description

Other Exchanges CLBT:USA9W9:Germany
Address 94 Shlomo Shmelzer Road, P.O. Box 3925, Petah Tikva, ISR, 4970602
Cellebrite DI Ltd provides AI-powered digital investigative and intelligence solutions that help public and private sector customers transform investigative workflows, make digital data more accessible and actionable, and improve the efficiency of mobile research and application security. Its solutions support law enforcement, defense, and intelligence agencies in advancing investigations, border security, counterterrorism, intelligence operations, and cyber operations. The company's software also enables enterprises and service providers to collect and review data for corporate investigations, eDiscovery, incident response, and mobile application validation. It operates in the Americas, APAC, and EMEA, with the majority of revenue from the Americas.
85GF Score

Get the complete analysis for CLBTW

Cash Flow from Financing is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$5.25
Price